Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction

• Published in: Journal of Lipids Vol. 2016; no. 2016; pp. 41 - 47
• Main Authors: Solheim, Svein, Tveit, Arnljot, Myhre, Peder, Schmidt, Erik B., Seljeflot, Ingebjørg, Laake, Kristian, Arnesen, Harald
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Limiteds 01.01.2016; Hindawi Publishing Corporation; John Wiley & Sons, Inc; Wiley
• Subjects: Aged; Analysis; Antilipemic agents; Atrial fibrillation; Cardiac patients; Cardiovascular diseases; Comorbidity; Fatty acids; Health aspects; Heart attack; Omega-3 fatty acids; Risk factors; Serum; Unsaturated fatty acids; Norway
• ISSN: 2090-3030; 2090-3049
• DOI: 10.1155/2016/4945720

Background. Epidemiological and randomized clinical trials indicate that marine polyunsaturated n-3 fatty acids (n-3 PUFAs) may have cardioprotective effects. Aim. Evaluate the associations between serum fatty acid profile, traditional risk factors, the presence of cardiovascular diseases (CVD), and peak Troponin T (TnT) levels in elderly patients with an acute myocardial infarction (AMI). Materials and Methods. Patients ( n = 299 ) consecutively included in the ongoing Omega-3 fatty acids in elderly patients with myocardial infarction (OMEMI) trial were investigated. Peak TnT was registered during the hospital stay. Serum fatty acid analysis was performed 2–8 weeks later. Results. No significant correlations between peak TnT levels and any of the n-3 PUFAs were observed. However, patients with a history of atrial fibrillation had significantly lower docosahexaenoic acid levels than patients without. Significantly lower peak TnT levels were observed in patients with a history of hyperlipidemia, angina, MI, atrial fibrillation, intermittent claudication, and previous revascularization (all p < 0.02 ). Conclusions. In an elderly population with AMI, no association between individual serum fatty acids and estimated myocardial infarct size could be demonstrated. However, a history of hyperlipidemia and the presence of CVD were associated with lower peak TnT levels, possibly because of treatment with cardioprotective medications.